5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors

Ann Oncol. 1991 Feb;2(2):153. doi: 10.1093/oxfordjournals.annonc.a057881.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biliary Tract Neoplasms / drug therapy*
  • Biliary Tract Neoplasms / mortality
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Male
  • Middle Aged
  • Mitomycin
  • Mitomycins / administration & dosage
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / mortality
  • Survival Rate

Substances

  • Mitomycins
  • Mitomycin
  • Fluorouracil
  • Ifosfamide

Supplementary concepts

  • FIM protocol